BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bretagne JF, Honnorat C, Richard-molard B, Caekaert A, Barthelemy P. Comparative study of characteristics and disease management between subjects with frequent and occasional gastro-oesophageal reflux symptoms. Aliment Pharmacol Ther 2006;23:607-16. [DOI: 10.1111/j.1365-2036.2006.02811.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Ferguson DD, DeVault KR. Medical management of gastroesophageal reflux disease. Expert Opin Pharmacother. 2007;8:39-47. [PMID: 17163805 DOI: 10.1517/14656566.8.1.39] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
2 Flameling RD, Numans ME, ter Linde J, de Wit NJ, Siersema PD. Different characteristics of patients with gastro-oesophageal reflux disease on their path through healthcare: a population follow-up study. European Journal of Gastroenterology & Hepatology 2010;22:578-82. [DOI: 10.1097/meg.0b013e328335638c] [Cited by in Crossref: 7] [Article Influence: 0.6] [Reference Citation Analysis]
3 Wahlqvist P, Karlsson M, Johnson D, Carlsson J, Bolge SC, Wallander MA. Relationship between symptom load of gastro-oesophageal reflux disease and health-related quality of life, work productivity, resource utilization and concomitant diseases: survey of a US cohort. Aliment Pharmacol Ther. 2008;27:960-970. [PMID: 18315585 DOI: 10.1111/j.1365-2036.2008.03671.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 4.2] [Reference Citation Analysis]
4 Zalar A, Haddouche B, Antonietti M, Alhameedi R, Iwanicki-caron I, Lecleire S, Ducrotté P. Lack of Correlation Between Morbid Obesity and Severe Gastroesophageal Reflux Disease in Candidates for Bariatric Surgery: Results of a Large Prospective Study. OBES SURG 2013;23:1939-41. [DOI: 10.1007/s11695-013-1064-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
5 Dorval E, Rey JF, Soufflet C, Halling K, Barthélemy P. Perspectives on gastroesophageal reflux disease in primary care: the REFLEX study of patient-physician agreement. BMC Gastroenterol 2011;11:25. [PMID: 21435198 DOI: 10.1186/1471-230X-11-25] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
6 Kawai T, Hirayama Y, Oguchi A, Ishii F, Matushita M, Kitayama N, Morishita S, Hiratsuka N, Ohata K, Konishi H, Kishino M, Nakamura S. Effects of rikkunshito on quality of life in patients with gastroesophageal reflux disease refractory to proton pump inhibitor therapy. J Clin Biochem Nutr 2017;60:143-5. [PMID: 28366995 DOI: 10.3164/jcbn.16-77] [Reference Citation Analysis]
7 El-Serag H, Becher A, Jones R. Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies. Aliment Pharmacol Ther. 2010;32:720-737. [PMID: 20662774 DOI: 10.1111/j.1365-2036.2010.04406.x] [Cited by in Crossref: 153] [Cited by in F6Publishing: 129] [Article Influence: 13.9] [Reference Citation Analysis]
8 Chey WD, Mody RR, Izat E. Patient and Physician Satisfaction with Proton Pump Inhibitors (PPIs): Are There Opportunities for Improvement? Dig Dis Sci 2010;55:3415-22. [DOI: 10.1007/s10620-010-1209-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
9 Ben Chaabane N, Eljeridi N, Ben Salem K, Loghmeri H, Melki W, Hellara O, Bdioui F, Safer L, Soltani M, Saffar H. [What are the distinctive characteristics of subjects with frequent and occasional gastroesophageal reflux symptoms?]. Rev Epidemiol Sante Publique 2011;59:424-30. [PMID: 22000042 DOI: 10.1016/j.respe.2011.06.005] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
10 Alexandropoulou K, van Vlymen J, Reid F, Poullis A, Kang JY. Temporal trends of Barrett’s oesophagus and gastro-oesophageal reflux and related oesophageal cancer over a 10-year period in England and Wales and associated proton pump inhibitor and H2RA prescriptions: a GPRD study. Eur J Gastroenterol Hepatol. 2013;25:15-21. [PMID: 23022985 DOI: 10.1097/meg.0b013e3283595086] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
11 Boardman HF, Heeley G. The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitors. Int J Clin Pharm 2015;37:709-16. [PMID: 26100836 DOI: 10.1007/s11096-015-0150-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
12 Bretagne J, Honnorat C, Richard-molard B, Soufflet C, Barthélemy P. Management of gastroesophageal reflux disease by primary care physicians and gastroenterologists: A prospective study of patients’ records. Gastroentérologie Clinique et Biologique 2008;32:995-1000. [DOI: 10.1016/j.gcb.2008.05.020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
13 Surdea Blaga T, Dumitrascu D, Galmiche J, Bruley des Varannes S. Functional heartburn: clinical characteristics and outcome. European Journal of Gastroenterology & Hepatology 2013;25:282-90. [DOI: 10.1097/meg.0b013e32835b108f] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
14 Bor S, Kitapcioglu G, Dettmar P, Baxter T. Association of Heartburn During Pregnancy With the Risk of Gastroesophageal Reflux Disease. Clinical Gastroenterology and Hepatology 2007;5:1035-9. [DOI: 10.1016/j.cgh.2007.05.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
15 Nusrat S, Nusrat S, Bielefeldt K. Reflux and sex: what drives testing, what drives treatment? Eur J Gastroenterol Hepatol 2012;24:233-47. [PMID: 22186188 DOI: 10.1097/MEG.0b013e32834f6baa] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
16 Fang X, Zhu L, Wu D, Wang Z, Fei G, Chang M, Liu F, Xin H, Xu T, Chen W, Wen P, Li S, Zhao W, Chen W, Yao F, Sun X, Han S, Ke M. Natural history of gastroesophageal reflux: A prospective cohort study in a stratified, randomized population in Beijing. J Dig Dis 2019;20:523-31. [PMID: 31291055 DOI: 10.1111/1751-2980.12799] [Reference Citation Analysis]
17 Hungin AP, Hill C, Raghunath A. Systematic review: frequency and reasons for consultation for gastro-oesophageal reflux disease and dyspepsia. Aliment Pharmacol Ther. 2009;30:331-342. [PMID: 19660016 DOI: 10.1111/j.1365-2036.2009.04047.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
18 Johnson DA, Katz PO, Armstrong D, Cohen H, Delaney BC, Howden CW, Katelaris P, Tutuian RI, Castell DO. The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus. Drugs 2017;77:547-61. [PMID: 28233274 DOI: 10.1007/s40265-017-0712-6] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
19 Bytzer P. What makes individuals with gastroesophageal reflux disease dissatisfied with their treatment? Clin Gastroenterol Hepatol. 2009;7:816-822. [PMID: 19286478 DOI: 10.1016/j.cgh.2009.03.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
20 van Zanten SJ, Henderson C, Hughes N. Patient satisfaction with medication for gastroesophageal reflux disease: a systematic review. Can J Gastroenterol 2012;26:196-204. [PMID: 22506259 DOI: 10.1155/2012/235476] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
21 Rey E, Barceló M, Zapardiel J, Sobreviela E, Muñoz M, Díaz-Rubio M. Is the reflux disease questionnaire useful for identifying GERD according to the Montreal definition? BMC Gastroenterol 2014;14:17. [PMID: 24450939 DOI: 10.1186/1471-230X-14-17] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
22 García Rodríguez LA, Ruigómez A, Martín-Merino E, Johansson S, Wallander MA. Relationship between gastroesophageal reflux disease and COPD in UK primary care. Chest 2008;134:1223-30. [PMID: 18689591 DOI: 10.1378/chest.08-0902] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 3.0] [Reference Citation Analysis]
23 Chor WPD, Yong PXL, Lim LL, Chai CY, Sim TB, Kuan WS. Management of dyspepsia-The role of the ED Observation unit to optimize patient outcomes. Am J Emerg Med 2018;36:1733-7. [PMID: 29444751 DOI: 10.1016/j.ajem.2018.01.057] [Reference Citation Analysis]
24 Kawai T, Hirayama Y, Oguchi A, Ishii F, Matushita M, Kitayama N, Morishita S, Hiratsuka N, Ohata K, Konishi H, Kishino M, Nakamura S. Effects of rikkunshito on quality of life in patients with gastroesophageal reflux disease refractory to proton pump inhibitor therapy. J Clin Biochem Nutr 2017;60:143-5. [PMID: 28366995 DOI: 10.3164/jcbn.16-77] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
25 Bretagne JF, Honnorat C, Richard-Molard B, Soufflet C, Barthélemy P. Perceptions and practices on the management of gastro-oesophageal reflux disease: results of a national survey comparing primary care physicians and gastroenterologists. Aliment Pharmacol Ther 2007;25:823-33. [PMID: 17373921 DOI: 10.1111/j.1365-2036.2007.03265.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
26 El-Serag H, Hill C, Jones R. Systematic review: the epidemiology of gastro-oesophageal reflux disease in primary care, using the UK General Practice Research Database. Aliment Pharmacol Ther 2009;29:470-80. [PMID: 19035977 DOI: 10.1111/j.1365-2036.2008.03901.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 47] [Article Influence: 4.3] [Reference Citation Analysis]
27 Tuppin P, Rivière S, Deutsch D, Gastaldi-Menager C, Sabaté JM. Burden of drug use for gastrointestinal symptoms and functional gastrointestinal disorders in France: a national study using reimbursement data for 57 million inhabitants. Therap Adv Gastroenterol 2019;12:1756284819853790. [PMID: 31320929 DOI: 10.1177/1756284819853790] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
28 Cohen E, Bolus R, Khanna D, Hays RD, Chang L, Melmed GY, Khanna P, Spiegel B. GERD symptoms in the general population: prevalence and severity versus care-seeking patients. Dig Dis Sci. 2014;59:2488-2496. [PMID: 24811245 DOI: 10.1007/s10620-014-3181-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
29 Mousa HM, Rosen R, Woodley FW, Orsi M, Armas D, Faure C, Fortunato J, O’connor J, Skaggs B, Nurko S. Esophageal impedance monitoring for gastroesophageal reflux. J Pediatr Gastroenterol Nutr. 2011;52:129-139. [PMID: 21240010 DOI: 10.1097/mpg.0b013e3181ffde67] [Cited by in Crossref: 80] [Cited by in F6Publishing: 30] [Article Influence: 7.3] [Reference Citation Analysis]
30 Crump C, Winkleby MA, Sundquist J, Sundquist K. Gestational age at birth and risk of gastric acid-related disorders in young adulthood. Ann Epidemiol 2012;22:233-8. [PMID: 22382080 DOI: 10.1016/j.annepidem.2012.02.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
31 Ferrús JA, Zapardiel J, Sobreviela E. Management of gastroesophageal reflux disease in primary care settings in Spain: SYMPATHY I study. Eur J Gastroenterol Hepatol. 2009;21:1269-1278. [PMID: 19474743 DOI: 10.1097/meg.0b013e32832a7d9b] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
32 Ben Chaabane N, El Jeridi N, Ben Salem K, Hellara O, Loghmari H, Melki W, Bdioui F, Safer L, Soltani M, Saffar H. Prevalence of gastroesophageal reflux in a Tunisian primary care population determined by patient interview. Dis Esophagus. 2012;25:4-9. [PMID: 21595777 DOI: 10.1111/j.1442-2050.2011.01205.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
33 Nasseri-Moghaddam S, Mofid A, Ghotbi MH, Razjouyan H, Nouraie M, Ramard AR, Zaer-Rezaie H, Habibi R, Rafat-Zand K, Malekzadeh R. Epidemiological study of gastro-oesophageal reflux disease: reflux in spouse as a risk factor. Aliment Pharmacol Ther 2008;28:144-53. [PMID: 18410559 DOI: 10.1111/j.1365-2036.2008.03708.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]